Zepp Health Corporation
ZEPP
$2.57
-$0.16-5.86%
NYSE
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -49.31% | -42.52% | -42.52% | -41.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -49.31% | -42.52% | -42.52% | -41.82% |
| Cost of Revenue | -- | -56.88% | -47.38% | -47.37% | -44.31% |
| Gross Profit | -- | -16.29% | -22.33% | -22.32% | -31.28% |
| SG&A Expenses | -- | -30.04% | -31.19% | -31.24% | -29.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -50.24% | -43.30% | -43.32% | -40.31% |
| Operating Income | -- | 59.47% | 51.02% | 51.21% | 18.48% |
| Income Before Tax | -- | 59.47% | 37.31% | 37.54% | -26.02% |
| Income Tax Expenses | -- | 111.60% | 75.40% | 75.40% | 41.13% |
| Earnings from Continuing Operations | -- | 48.02% | 28.65% | 28.92% | -49.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -36.17% | -35.34% | -35.73% | 6.46% |
| Net Income | -- | 48.05% | 28.64% | 28.91% | -49.58% |
| EBIT | -- | 59.47% | 51.02% | 51.21% | 18.48% |
| EBITDA | -- | 68.30% | 58.72% | 58.97% | 22.65% |
| EPS Basic | -- | 49.51% | 28.00% | 28.29% | -50.38% |
| Normalized Basic EPS | -- | 69.67% | 50.40% | 50.65% | -30.57% |
| EPS Diluted | -- | 49.50% | 28.38% | 28.59% | -48.43% |
| Normalized Diluted EPS | -- | 69.61% | 50.35% | 50.58% | -29.96% |
| Average Basic Shares Outstanding | -- | 0.71% | -1.20% | -1.20% | -1.73% |
| Average Diluted Shares Outstanding | -- | 2.03% | 0.12% | 0.12% | -1.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |